Med Life Sa · BVB:M

Med Life Sa — 9M 2019 Earnings Presentation

28 slides from Med Life Sa's earnings presentation, December 2019

  1. Slide 1: Investors and Analysts Presentation

    The Largest Ecosystem on the private healthcare market in Romania One of the largest private healthcare companies in Central and Eastern Europe Investors and Analysts Presentation December, 2019

  2. Slide 2: Legal Disclaimer

    LEGAL DISCLAIMER This presentation is not, and nothing in it should be construed as an offer, invitation or recommendation in respect of Med Life SA’s securities, or an offer, invitation or recommendation to sell, or a solicitation of an offer to buy Med Life SA’s securities. Neither this presentati

  3. Slide 3: Contents

    CONTENTS PAGE I. INTRODUCTION TO MEDLIFE ………… 4 A. KEY INVESTMENT HIGHLIGHTS ………… 5 B. HOW WE GREW ………… 7 C. MEDLIFE NETWORK ………… 10 D. BUSINESS OVERVIEW ………… 11 E. 2019 KEY EVENTS ………… 14 II. MARKET OVERVIEW ………… 16 III. GROUP FINANCIAL SNAPSHOT A. 9m 2019 KEY MESSAGES ………… 20 B. 9m 2019 FINANCIAL

  4. Slide 4: I. Introduction to MedLife

    I. INTRODUCTION TO MEDLIFE Founded in 1996, MedLife is the leading private healthcare provider in Romania*. The Company operates the widest network of clinics, one of the largest networks of medical laboratories, general and specialised hospitals and it has the largest client database for Healthcare

  5. Slide 5: A. Key Investment Highlights

    A. KEY INVESTMENT HIGHLIGHTS ▪ Expected - highest growth of healthcare market in CEE with a 1 Romania – attractive & growing healthcare market CAGR for private healthcare of 9.6% over 2018 – 2023 ▪ Pro-Forma Sales 2018: RON 804 mln MedLife - the leading private healthcare operator in 2 Romania and o

  6. Slide 6: Unique Revenue Capture Model - Flow of Referrals

    THE LARGEST ECOSYSTEM ON THE PRIVATE HEALTHCARE MARKET Unique Revenue Capture Model - Flow of Referrals Among Business Lines CLIENT BASE SOURCES OF MED LIFE BUSINESS PAYMENT LINES % of Total Sales 9m 2019 Clinics 19% NHIH Clients paying out of pocket or covered by NHIH Laboratories Referrals Trust b

  7. Slide 7: B. How We Grew

    B. HOW WE GREW 2010 2016 1999 2004 MedLife crossed the country`s boarders and announced the first international transaction in Hungary Our own pharmacy chain is launched, PharmaLife MedLife develops a new business division, Stomatology, as well as the second brand, “Sfânta 1996 The first own The fir

  8. Slide 8: Successful Track Record in Organic Growth and Acquisitions

    SUCCESSFUL TRACK RECORD IN MANAGEMENT OF ORGANIC GROWTH AND ACQUISITIONS ORGANIC 2019 ACQUISTIONS LEGEND Hyperclinics Clinics Hospitals Pharmacies Laboratories Dental Clinics * data as at September 2019 M E D L I F E G R O U P I n v e s t o r s a n d A n a l y s t s P r e s e n t a t i o n | Page 8

  9. Slide 9: National Footprint Captures Growth in All Regions

    NATIONAL FOOTPRINT CAPTURES GROWTH IN ALL REGIONS HYPERCLINICS/CLINICS H O S P I TA L S L A B O R AT O R I E S & S P S 1 1 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 1 1 2 1 2 3 1 1 1 1 1 1 2 1 2 2 1 6 1 1 1 1 1 4 1 2 18 7 1 2 11 1 1 3 1 1 1 1 1 Legend: Day inpatient Inpatient Legend: Laboratories Sampling Point

  10. Slide 10: C. MedLife Network

    C. MEDLIFE NETWORK The two brands of MedLife Group - the only private medical Romanian service company that can use its synergies at national level to capture competitive advantages MEDLIFE BRAND NETWORK SFANTA MARIA BRAND NETWORK 20 Hyperclinics 39 Clinics 10 Clinics 10 Hospitals 25 Laboratories 8

  11. Slide 11: D. Business Overview

    D. BUSINESS OVERVIEW HEALTHCARE PREVENTION CLINICS HOSPITALS LABORATORIES PHARMACIES STOMATOLOGY PACKAGES (HPP) Mandatory Outpatient services Maternity, specialist Full range of tests Prescription, OTC Wide range of dental ALL KEY occupational health including Imagistics. and generalist facilities p

  12. Slide 12: Business Segments: Hyperclinics and Clinics

    BUSINESS SEGMENTS MEDLIFE: A PIONEER IN LARGE SCALE CLINICS AND LARGE SCALE HIGH-END LAB OPERATION • One stop shop concept - MedLife hyperclinics includes medical ambulatory specialties, providing in one single place: clinical examinations and imaging • Hyperclinics have over 20 medical offices and

  13. Slide 13: Business Segments: Hospitals

    BUSINESS SEGMENTS MEDLIFE: LARGEST OPERATOR OF PRIVATE HOSPITALS* • MedLife hospitals cover a wide range of medical and surgical specializations, reuniting the best medical staff, with significant national and international expertise • 10 hospitals – 7 inpatient hospitals and 3 day inpatient. Life M

  14. Slide 14: E. 2019 Key Events: Acquisitions

    E. 2019 KEY EVENTS ACQUISITIONS • 51% of the shares in RMC Group, Hungary (finalized in March 2019) • 65% of the shares in Badea Medica Center of Excellence in Cluj (finalized in May 2019) • Increase from 55% to 90% shares in Sama Group, Craiova • Increase from 80% to 83% shares in PDR Group, Brasov

  15. Slide 15: E. 2019 Key Events (Cont.)

    E. 2019 KEY EVENTS (Cont.) ORGANIC GROWTH • 2 Dent Estet clinics in Sibiu – one for adults, one for kids; • Floreasca Hyperclinic in Bucharest- brownfield project (inaugurated in October 2019) • The second Hyperclinic in Galati - brownfield project (inaugurated in November 2019) EXPANSION PLANS • Ad

  16. Slide 16: Favourable Macroeconomic Environment

    II. MARKET OVERVIEW FAVOURABLE MACROECONOMIC ENVIRONMENT • The Romanian economy expanded by 4.1% in 9m 2019 as compared to 9m 2018 and 4.1% YoY in 2018 (2017: 6.9%; 2016: 4.8%) as compared to EU which expanded by 1.9% YoY in 2018. According to European Commission forecasts, Romanian GDP is expected

  17. Slide 17: Favourable Macroeconomic Environment

    II. MARKET OVERVIEW FAVOURABLE MACROECONOMIC ENVIRONMENT CHANGE OF GDP PER INHABITANT IN PURCHASING POWER STANDARDS (PPS) IN RELATION TO THE EU-28 AVERAGE, 2007-2016 (percentage points difference between 2007 and 2016) • Romania has increased with 5-<10 and more than 10 percentage points in certain

  18. Slide 18: Healthcare Market Growth Fundamentals

    II. MARKET OVERVIEW HEALTHCARE MARKET GROWTH FUNDAMENTALS • In terms of health care expenditure as a percentage of GDP, the highest figure recorded in 2016 was in France (11.5 %), followed by Germany (11.1 %) and Growth fundamentals Sweden (10.9 %). The three EU countries with the lowest shares of G

  19. Slide 19: Healthcare Market Assessment

    II. MARKET OVERVIEW HEALTHCARE MARKET ASSESSMENT Value (EUR bn) and change (%) of the private healthcare market in Central Europe, 2015-2023 Private healthcare Because the development of private investment was market boosted by the recently introduced tax deductibility, Outpacing the rest of CE priv

  20. Slide 20: A. 9m 2019 Key Messages

    III. GROUP FINANCIAL SNAPSHOT A. 9m 2019 KEY MESSAGES Sales increased by : + 20.1% Pro-forma 9m 2019 vs. IFRS 9m 2018 SALES + 22.7% IFRS 9m 2019 vs. IFRS 9m 2018 + 14.9% like2like Improved margin: 13.1% Pro-forma 9m 2019 vs. 12.1% IFRS 9m 2018 (fig_1) (before IFRS 16) 17.1% Pro-forma 9m 2019 vs. 12.

  21. Slide 21: A. 9m 2019 Key Messages (Cont.)

    III. GROUP FINANCIAL SNAPSHOT A. 9m 2019 KEY MESSAGES (Cont.) Split of Pro-forma EBITDA between Owners of the Group / NCI for 9m 2019: 9.3% 90.7% - 90.7% to Group Owners EBITDA - 9.3% to NCI Pro-forma EBITDA to Group Owners Pro-forma EBITDA to NCI Improved margin: 6.8% Pro-forma 9m 2019 vs. 4.8% IFR

  22. Slide 22: Consolidated Statement of Financial Position

    III. GROUP FINANCIAL SNAPSHOT B. 9m 2019 FINANCIAL RESULTS Consolidated Statement of Financial Position M E D L I F E G R O U P I n v e s t o r s a n d A n a l y s t s P r e s e n t a t i o n | Page 22

  23. Slide 23: Consolidated Statement of Profit and Loss

    III. GROUP FINANCIAL SNAPSHOT B. 9m 2019 FINANCIAL RESULTS (Cont.) Consolidated Statement of Profit and Loss M E D L I F E G R O U P I n v e s t o r s a n d A n a l y s t s P r e s e n t a t i o n | Page 23

  24. Slide 24: Consolidated Statement of Cash Flow

    III. GROUP FINANCIAL SNAPSHOT B. 9m 2019 FINANCIAL RESULTS (Cont.) Consolidated Statement of Cash Flow M E D L I F E G R O U P I n v e s t o r s a n d A n a l y s t s P r e s e n t a t i o n | Page 24

  25. Slide 25: OPEX Evolution

    III. GROUP FINANCIAL SNAPSHOT B. 9m 2019 FINANCIAL RESULTS (Cont.) OPEX Evolution Note: The Group recorded a 1.5 p.p. decrease of Operating Expenses as % of Sales in 9m 2019 as compared to 9m 2018: A. 4.6 p.p. decrease of “Rent” as % of Sales, generated by first time adoption of IFRS 16; B. 1.0 p.p.

  26. Slide 26: Operational KPIs

    III. GROUP FINANCIAL SNAPSHOT B. 9m 2019 FINANCIAL RESULTS (Cont.) Operational KPIs M E D L I F E G R O U P I n v e s t o r s a n d A n a l y s t s P r e s e n t a t i o n | Page 26

  27. Slide 27: C. Mission Statement & Evolution

    III. GROUP FINANCIAL SNAPSHOT C. MISSION STATEMENT & EVOLUTION 2016 IFRS 2017 IFRS 2018 Pro-forma IFRS Consistent track record of strong 502.9 mRON 623.2 mRON, increased by 24% 804 mRON, increased by 29% growth of Sales MedLife units as at 31 December MedLife units as at 31 December MedLife units as

  28. Slide 28: C. Mission Statement & Evolution

    III. GROUP FINANCIAL SNAPSHOT C. MISSION STATEMENT & EVOLUTION 2016 IFRS 2017 IFRS 2018 Pro-forma IFRS EBITDA evolution in 54.6 mRON 77.9 mRON, increased by 43% 103.4 mRON, increased by 32.7% absolute figures Sustainable and improved EBITDA 10.9% EBITDA margin 12.5% EBITDA margin 12.9% EBITDA margin

Med Life — 9M 2019 Earnings Presentation on 6ix